These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23733753)

  • 21. Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities.
    Basch E; Artz D; Iasonos A; Speakman J; Shannon K; Lin K; Pun C; Yong H; Fearn P; Barz A; Scher HI; McCabe M; Schrag D
    J Am Med Inform Assoc; 2007; 14(3):264-8. PubMed ID: 17329732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of lung cancer relapse using self-reported symptoms transmitted via an internet web-application: pilot study of the sentinel follow-up.
    Denis F; Viger L; Charron A; Voog E; Dupuis O; Pointreau Y; Letellier C
    Support Care Cancer; 2014 Jun; 22(6):1467-73. PubMed ID: 24414998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial.
    Krzyzanowska MK; Julian JA; Gu CS; Powis M; Li Q; Enright K; Howell D; Earle CC; Gandhi S; Rask S; Brezden-Masley C; Dent S; Hajra L; Freeman O; Spadafora S; Hamm C; Califaretti N; Trudeau M; Levine MN; Amir E; Bordeleau L; Chiarotto JA; Elser C; Husain J; Laferriere N; Rahim Y; Robinson AG; Vandenberg T; Grunfeld E
    BMJ; 2021 Dec; 375():e066588. PubMed ID: 34880055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial.
    Graetz I; McKillop CN; Stepanski E; Vidal GA; Anderson JN; Schwartzberg LS
    J Cancer Surviv; 2018 Aug; 12(4):431-440. PubMed ID: 29492753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of transitioning inpatient chemotherapy regimens to the outpatient setting.
    Corsi MP; Shea K; W Knoebel R
    J Oncol Pharm Pract; 2020 Sep; 26(6):1324-1330. PubMed ID: 31822200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Survey of pain after ambulatory surgery: An internet-based instrument].
    Schwarze C; Zenz D; Orlowski O; Wempe C; Van Aken H; Zahn P; Maier C; Pogatzki-Zahn EM
    Schmerz; 2016 Apr; 30(2):141-51. PubMed ID: 26541856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-World Costs of Adverse Events in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer.
    Engel-Nitz NM; Johnson MP; Bunner SH; Ryan KJ
    J Manag Care Spec Pharm; 2020 Jun; 26(6):729-740. PubMed ID: 32463768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes evaluation of a weekly nurse practitioner-managed symptom management clinic for patients with head and neck cancer treated with chemoradiotherapy.
    Mason H; DeRubeis MB; Foster JC; Taylor JM; Worden FP
    Oncol Nurs Forum; 2013 Nov; 40(6):581-6. PubMed ID: 24007925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AMTRA: a multicentered experience of a web-based monitoring and tailored toxicity management system for cancer patients.
    Rasschaert M; Vulsteke C; De Keersmaeker S; Vandenborne K; Dias S; Verschaeve V; Vuylsteke P; Brussel IV; Ravelingien J; Dam PV; Segelov E; Peeters M
    Support Care Cancer; 2021 Feb; 29(2):859-867. PubMed ID: 32519044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis.
    Frogel MP; Stewart DL; Hoopes M; Fernandes AW; Mahadevia PJ
    J Manag Care Pharm; 2010; 16(1):46-58. PubMed ID: 20131495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-world evaluation of effectiveness and tolerance of chemotherapy for early-stage breast cancer in older women.
    Delgado-Ramos GM; Nasir SS; Wang J; Schwartzberg LS
    Breast Cancer Res Treat; 2020 Jul; 182(2):247-258. PubMed ID: 32447595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes.
    Basch E; Jia X; Heller G; Barz A; Sit L; Fruscione M; Appawu M; Iasonos A; Atkinson T; Goldfarb S; Culkin A; Kris MG; Schrag D
    J Natl Cancer Inst; 2009 Dec; 101(23):1624-32. PubMed ID: 19920223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An online community improves adherence in an internet-mediated walking program. Part 1: results of a randomized controlled trial.
    Richardson CR; Buis LR; Janney AW; Goodrich DE; Sen A; Hess ML; Mehari KS; Fortlage LA; Resnick PJ; Zikmund-Fisher BJ; Strecher VJ; Piette JD
    J Med Internet Res; 2010 Dec; 12(4):e71. PubMed ID: 21169160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with grade 3 or 4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of NRG Oncology/Gynecologic Oncology Group trials 179 and 204.
    Chase DM; Kauderer J; Wenzel L; Ramondetta L; Cella D; Long HJ; Monk BJ
    Int J Gynecol Cancer; 2015 Feb; 25(2):303-8. PubMed ID: 25405577
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.